0.95
price down icon0.02%   -0.0002
after-market Dopo l'orario di chiusura: .95
loading
Precedente Chiudi:
$0.9502
Aprire:
$0.9521
Volume 24 ore:
4,811
Relative Volume:
0.02
Capitalizzazione di mercato:
$4.83M
Reddito:
-
Utile/perdita netta:
$-21.13M
Rapporto P/E:
-0.1983
EPS:
-4.79
Flusso di cassa netto:
$-16.95M
1 W Prestazione:
-5.00%
1M Prestazione:
+7.94%
6M Prestazione:
+59.13%
1 anno Prestazione:
+463.46%
Intervallo 1D:
Value
$0.95
$0.98
Intervallo di 1 settimana:
Value
$0.9115
$1.04
Portata 52W:
Value
$0.09
$4.49

Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile

Name
Nome
Matinas Biopharma Holdings Inc
Name
Telefono
908-443-1860
Name
Indirizzo
1545 Route 206 South, Suite 302, Bedminster, NJ
Name
Dipendente
15
Name
Cinguettio
@MatinasBio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
MTNB's Discussions on Twitter

Confronta MTNB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MTNB
Matinas Biopharma Holdings Inc
0.95 4.83M 0 -21.13M -16.95M -4.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-05-11 Downgrade Piper Sandler Overweight → Neutral
2020-08-26 Ripresa Piper Sandler Overweight
2020-01-27 Iniziato Piper Sandler Overweight
2020-01-24 Iniziato SunTrust Buy
2020-01-23 Iniziato SunTrust Buy
2020-01-09 Iniziato Aegis Capital Buy
2019-06-26 Iniziato H.C. Wainwright Buy
Mostra tutto

Matinas Biopharma Holdings Inc Borsa (MTNB) Ultime notizie

pulisher
Jul 23, 2025

Is Matinas BioPharma Holdings Inc. a good long term investmentBreakthrough profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about HASI stockFree Investment Timing Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Matinas BioPharma Holdings Inc. stock performs during market volatilitySmart Return Focused Trading - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Matinas BioPharma Holdings Inc. Stock Analysis and ForecastBreakout profit opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Matinas BioPharma Holdings Inc. stock priceFree Stock Market Mentorship - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Matinas BioPharma Holdings Inc. stockExceptional portfolio growth - Autocar Professional

Jul 22, 2025
pulisher
Jul 19, 2025

Is Renovaro Inc. a good long term investmentSuperior capital gains - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What makes Matinas BioPharma Holdings Inc. stock price move sharplyShort Squeeze Radar - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about WRAP stockOutstanding capital returns - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 15, 2025

Why Matinas BioPharma Holdings Inc. stock attracts strong analyst attentionQuick Profit Idea Stream - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Hayward Holdings Inc. stock attracts strong analyst attentionFree Stock Movement Tracking - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Aspergillosis Pipeline 2025: FDA Updates, Therapy - openPR.com

Jul 10, 2025
pulisher
Jul 10, 2025

Diversification Wins: Global ETFs Shine in First Half of 2025 - The Globe and Mail

Jul 10, 2025
pulisher
Jun 23, 2025

Matinas BioPharma Approves 2025 Equity Incentive Plan - TipRanks

Jun 23, 2025
pulisher
Jun 12, 2025

MTNB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jun 12, 2025
pulisher
Jun 12, 2025

Pre-market Movers: HCTI, KLTO, INTS, HSDT... - RTTNews

Jun 12, 2025
pulisher
Jun 06, 2025

Kalkine Matinas BioPharma Surges Amid NYSE Composite Market Momentum - Kalkine Media

Jun 06, 2025
pulisher
Jun 06, 2025

Matinas Biopharma (NYSE:MTNB) Trading 5.7% Higher – Here’s Why - Defense World

Jun 06, 2025
pulisher
May 03, 2025

Matinas Biopharma (NYSE:MTNB) versus Marker Therapeutics (NASDAQ:MRKR) Head to Head Review - Defense World

May 03, 2025
pulisher
May 02, 2025

Matinas BioPharma amends bylaws, updates on officer agreements By Investing.com - Investing.com Canada

May 02, 2025
pulisher
May 02, 2025

Matinas BioPharma Amends Bylaws and Sets Annual Meeting - TipRanks

May 02, 2025
pulisher
May 02, 2025

Matinas BioPharma amends bylaws, updates on officer agreements - Investing.com

May 02, 2025
pulisher
Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025
pulisher
Apr 17, 2025

Matinas Biopharma (NYSE:MTNB) Shares Down 2.6% – Here’s What Happened - Defense World

Apr 17, 2025
pulisher
Apr 08, 2025

MTNB stock touches 52-week low at $0.48 amid sharp annual decline - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

MTNB stock touches 52-week low at $0.48 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 04, 2025

Matinas BioPharma secures shareholder nods on key proposals By Investing.com - Investing.com Australia

Apr 04, 2025

Matinas Biopharma Holdings Inc Azioni (MTNB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):